|
注册号: Registration number: |
ChiCTR2600118501 |
|
最近更新日期: Date of Last Refreshed on: |
2026-02-08 20:15:15 |
|
注册时间: Date of Registration: |
2026-02-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
血清代谢组在饮食生活方式与精子质量关联中的中介作用研究 |
|
Public title: |
Study on the Mediating Role of Serum Metabolome in the Association between Diet, Lifestyle and Sperm Quality |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
血清代谢组在饮食生活方式与精子质量关联中的中介作用研究 |
|
Scientific title: |
Study on the Mediating Role of Serum Metabolome in the Association between Diet, Lifestyle and Sperm Quality |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
马兴好 |
研究负责人: |
马兴好 |
|
Applicant: |
Xinghao Ma |
Study leader: |
Xinghao Ma |
|
申请注册联系人电话: Applicant telephone: |
+86 564 359 7034 |
研究负责人电话:
Study leader's |
+86 564 359 7034 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
271307026@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
271307026@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省六安市皖西西路21号 |
研究负责人通讯地址: |
安徽省六安市金安区皖西路21号 |
|
Applicant address: |
No. 21, West Wanxi Road, Lu 'an City, Anhui Province |
Study leader's address: |
No. 21, Wanxi Road, Jinan District, Luan City, Anhui Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
六安市人民医院 |
||
|
Applicant's institution: |
Lu 'an People's Hospital |
||
|
研究负责人所在单位: |
六安市人民医院 |
||
|
Affiliation of the Leader: |
Lu'an People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025LLKS-KY-062 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
六安市人民医院医学伦理审查委员会 |
||
|
Name of the ethic committee: |
The Institutional Review Board of the Lu'an People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-10-28 00:00:00 | ||
|
伦理委员会联系人: |
郭峰 |
||
|
Contact Name of the ethic committee: |
Guo Feng |
||
|
伦理委员会联系地址: |
安徽省六安市金安区皖西路21号 |
||
|
Contact Address of the ethic committee: |
No. 21, Wanxi Road, Jinan District, Luan City, Anhui Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 564 3338627 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
16081286@qq.com |
|
研究实施负责(组长)单位: |
六安市人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Lu'an People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省六安市金安区皖西路21号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 21, Wanxi Road, Jinan District, Luan City, Anhui Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
1、核心目标: 探讨高脂饮食、肥胖/超重、倒班等饮食生活方式因素与男性精子质量的关联性。 2、机制目标: 识别与不良生活方式和精子质量受损均相关的关键血清代谢物及代谢通路。 3、中介分析目标: 验证血清代谢组在生活方式暴露与精子质量关联中的中介效应,初步阐明其内在生物学机制。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Core objective: To explore the correlation between dietary and lifestyle factors such as high-fat diet, obesity/overweight, and shift work and male sperm quality. 2. Mechanism Objective: Identify key serum metabolites and metabolic pathways associated with both unhealthy lifestyles and impaired sperm quality. 3. Objective of mediating analysis: To verify the mediating effect of the serum metabolome in the association between lifestyle exposure and sperm quality, and to preliminarily clarify its underlying biological mechanism. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.有先天性生殖系统疾病、精索静脉曲张III度以上、泌尿生殖系统感染、染色体异常、近期服用影响精子药物或激素、诊断为无精子症者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Those with congenital reproductive system diseases, varicocele of grade III or above, urinary and reproductive system infections, chromosomal abnormalities, recent use of drugs or hormones that affect sperm, or diagnosed with azoospermia. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-01-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-03-01 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验公共管理平台ResMan (www.medresman.org), 研究结束后六个月时间内上传 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Clinical trial Public management platform ResMan (www.medresman.org), upload within six months after the end of the study |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 ResMan (www.medresman.org) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC ResMan (www.medresman.org) |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |